Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 327,803
  • Shares Outstanding, K 70,953
  • Annual Sales, $ 55,640 K
  • Annual Income, $ -33,870 K
  • 60-Month Beta 0.46
  • Price/Sales 5.93
  • Price/Cash Flow N/A
  • Price/Book 11.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.08
  • Number of Estimates 5
  • High Estimate -0.06
  • Low Estimate -0.10
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.49 +8.79%
on 04/17/19
5.37 -8.99%
on 04/01/19
-0.22 (-4.31%)
since 03/22/19
3-Month
4.02 +21.64%
on 01/24/19
5.37 -8.99%
on 04/01/19
+0.81 (+19.85%)
since 01/23/19
52-Week
1.70 +187.65%
on 05/11/18
5.37 -8.99%
on 04/01/19
+2.71 (+124.83%)
since 04/23/18

Most Recent Stories

More News
What Makes BioDelivery (BDSI) a New Buy Stock

BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BDSI : 4.89 (+5.84%)
New Research: Key Drivers of Growth for Teradyne, Lazard, Graphic Packaging Holding, Natus Medical, Flotek Industries, and BioDelivery Sciences International -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Teradyne, Inc. (NASDAQ:TER),...

TER : 44.59 (-0.58%)
GPK : 13.83 (+6.55%)
LAZ : 37.24 (+0.78%)
BDSI : 4.89 (+5.84%)
BABY : 24.65 (+2.97%)
FTK : 3.60 (+4.35%)
BioDelivery (BDSI) Up 7.8% Since Last Earnings Report: Can It Continue?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 4.89 (+5.84%)
BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M

BioDelivery Sciences (BDSI) announces acquisition of U.S. commercial rights to pain drug, Symproic, from Japanese company, Shinogi.

BDSI : 4.89 (+5.84%)
ANIP : 69.64 (+1.21%)
TEVA : 14.91 (+1.43%)
KMDA : 6.12 (-1.77%)
BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) ("BDSI" or the "Company") today announced the pricing of an underwritten public offering by the Company and a selling stockholder of 12,000,000 shares...

BDSI : 4.89 (+5.84%)
Shionogi Announces Licensing of Symproic(R) (naldemedine) to BioDelivery Sciences International Inc.

Shionogi Inc. (hereafter "Shionogi") announced today that BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated...

BDSI : 4.89 (+5.84%)
BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) ("BDSI" or the "Company") today announced that it is commencing an underwritten public offering of shares of common stock. In addition, the underwriters...

BDSI : 4.89 (+5.84%)
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic(R)

Long-term revenue potential of over $75 million for NME with IP protection through 2031

BDSI : 4.89 (+5.84%)
BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know

BioDelivery Sciences International (BDSI) closed at $5.06 in the latest trading session, marking a -1.65% move from the prior day.

BDSI : 4.89 (+5.84%)
BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know

BioDelivery Sciences International (BDSI) closed the most recent trading day at $5.30, moving +0.57% from the previous trading session.

BDSI : 4.89 (+5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade BDSI with:

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

2nd Resistance Point 5.26
1st Resistance Point 5.07
Last Price 4.89
1st Support Level 4.65
2nd Support Level 4.42

See More

52-Week High 5.37
Last Price 4.89
Fibonacci 61.8% 3.97
Fibonacci 50% 3.54
Fibonacci 38.2% 3.10
52-Week Low 1.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar